Skip to content

Clinical Study for Radioactive Dermatitis Treated by Compound Danxiong Granule

Clinical Study for Radioactive Dermatitis Treated by Compound Danxiong Granule

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021339
Enrollment
Unknown
Registered
2019-02-16
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radioactive Dermatitis

Interventions

Treatment group:Danxiong Granule
Control group:GEP

Sponsors

Cancer Institute & Hospital Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with malignant tumors confirmed by pathology or cytology; 2. Grade III skin reaction occurred in the radiation field within 90 days after radiotherapy for tumors (fused Wet Peeling and severe edema except for skin wrinkles); 3. ECOG PS score < 3; 4. Aged = 18 years; 5. No intellectual and mental disorders, normal language expression, judgment of their own symptoms, and can cooperate in evaluation; 6. Understanding and agreeing to receive the treatment and signing the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with malignant skin tumors such as skin cancer, malignant melanoma and skin lymphoma; 2. Patients wiht non-radiation-induced skin injury; 3. The skin lesions of patients were observed with neurodermatitis, eczema, psoriasis and other obvious skin diseases. 4. Patients with skin allergies to traditional Chinese medicine used in the institute.

Design outcomes

Primary

MeasureTime frame
Healing time of skin lesions in patients;

Secondary

MeasureTime frame
The time required for grade III skin lesion to recover to grade I skin lesion and the healing rate after 7 days treatment;

Countries

China

Contacts

Public ContactTian Aiping

Cancer Institute & Hospital Chinese Academy of Medical Sciences

aipingtian@126.com+86 13651395732

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026